Division of Hematology
|  |
Clinical/Academic Interests
Anemias, Myeloproliferative Disorders, Thrombocytopenia,
Hypercoaguable States
Research Interests
Dr. Moliterno’s major clinical research involves the study of the chronic
myeloproliferative disorders (MPDs) including polycythemia vera, essential
thrombocytosis and idiopathic myelofibrosis. Her research is focused on the
genetic and epigenetic lesions associated with the MPDs with the goal of
improving diagnosis and treatment for these disorders.
1981-1985 | B.A., Physics, Cornell University, Ithaca, New York |
| 1985-1989 | M.D., State University of New York at Buffalo |
1989-92 | Internship and Residency in Medicine, Bayview Medical Center, Johns Hopkins University, Baltimore, Maryland |
1992-94 | Clinical Hematology Fellowship, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland |
1994-98 | Hematology Research Fellowship, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland |
1998-2000 | Instructor in Medicine, Johns Hopkins University, Baltimore, Maryland |
2000-Present | Assistant Professor in Medicine, Johns Hopkins University, Baltimore, Maryland |
Selected Publications
Moliterno AR, Williams DM, Gutierrez-Alamillo LI, Salvatori R, Ingersoll R, Spivak JL. Mpl Baltimore: A Thrombopoietin Receptor Polymorphism Associated with Thrombocytosis. Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11444-7.
Mullaly AM, Vogelsang GB, Moliterno AR. Wasted sheep and premature infants: the role of trace metals in hematopoiesis. Blood Rev 2004 Dec;18(4):227-34.
Lanzkron S, Moliterno AR, Norris EJ, Gould SA, Segal J, Nuermberger EL, Ness PM. Polymerized human Hb use in acute chest syndrome: a case report. Transfusion 2002 Nov;42(11):1422-7
Moliterno AR, Spivak JL. Post-translational processing of the thrombopoietin receptor is impaired in polycythemia vera. Blood 94:2555-2561, 1999.
Moliterno AR, Hankins WD, Spivak JL. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. New Engl J Med 338:572-580, 1998.
Goerttler PS, März E, Johansson PL, Andreasson B, Kutti J, Moliterno AR, Marchioli R, Spivak JL, Pahl HL* for the MPD Research Consortium. ?Thrombotic and bleeding complications in four subpopulations of patients with essential thrombocythemia defined by c-Mpl protein expression and PRV-1 mRNA levels. Haematologica 2005;90:851-853.
Segal J, Moliterno AR. Platelet Counts Differ by Sex, Ethnicity, and Age in the United States. Ann Epidemiol. 2006 Feb;16(2):123-30
Moliterno AR, Williams D, Rogers O, Spivak JL. Molecular Mimicry in the Chronic Myeloproliferative Disorders: Reciprocity between Quantitative JAK2 V617F and Mpl Expression. Blood. 2006 Dec 1;108(12):3913-5. Epub 2006 Aug 15.
